The BBS9 gene helps build and maintain cilia, which are tiny structures on cells that act like sensing antennas throughout the body. This gene plays an important role in how the eyes, kidneys, brain, and other organs develop and function. If the BBS9 gene does not work properly, it can cause Bardet-Biedl syndrome, a genetic condition linked to vision loss, extra fingers or toes, weight gain, kidney problems, and learning or development differences.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or manage processes throughout the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they take place, and how strongly they are active. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
BBS9Gene function
What if the gene works
The BBS9 gene helps cells build and maintain cilia, tiny structures that sense signals. This supports cell communication needed for vision, kidney function, growth, and energy balance.
Risk
What if the gene does not work
Pathogenic variants in the BBS9 gene can cause Bardet-Biedl syndrome, often affecting vision, weight, kidneys, and learning or development. Effects can range from milder to more severe, which may influence when features appear and how strongly they affect someone.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the BBS9 gene usually does not lead to a treatment plan that differs from other Bardet-Biedl syndrome genes. For eligible people with Bardet-Biedl syndrome and obesity, setmelanotide may be used because it can reduce hunger and support weight loss. Most other treatment is guided by the person’s symptoms, not by the exact BBS gene involved.
Conditions associated with BBS9
Gene function
What if the gene works
Many cells use the BBS9 gene to manage tiny surface structures called primary cilia. These act like small antennae, helping cells sense and respond to signals. Understanding what the BBS9 gene does helps explain how cells stay organized from moment to moment.
The BBS9 gene helps build the BBSome, a protein team that works at primary cilia. Primary cilia are tiny antenna-like structures on many cells that help them notice outside signals.
Its protein helps move signal-catching proteins and other cargo to the right place in cilia. This steady transport keeps the cilia surface organized so signals can be handled in a controlled way.
By supporting cilia traffic, the BBS9 gene helps cells respond to cues about growth, timing, and their surroundings. This is part of normal cell communication in many tissues across the body.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, however, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
BBS9 gene variants can change the shape or stability of the BBS9 protein, so it may not join the BBSome complex properly. This can disrupt movement of key proteins in cilia (tiny hairlike structures on cells) and weaken cell signaling. Some variants leave partial activity, while more disruptive variants can result in little or no working protein. In Bardet-Biedl syndrome, that difference may influence how early features appear and how many body systems are affected.
How variants are linked to conditions
Pathogenic variants in the BBS9 gene cause Bardet-Biedl syndrome, so BBS9 gene changes are linked to Bardet-Biedl syndrome in a clear, well-established way. This inherited condition can affect daily life through vision loss, weight gain, extra fingers or toes, kidney problems, delayed puberty, and learning or developmental differences. People usually develop the condition when they inherit two disease-causing BBS9 variants, one from each parent.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and instead reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For BBS9, risk is mainly determined by genetics: a child usually develops a BBS9-related condition only if they inherit two changed copies, one from each parent. Symptom severity can vary, but clear lifestyle or environmental factors that change the chance of having the condition are not well established.
Inheritance of BBS9 variants
For families asking about the BBS9 inheritance pattern, disease-causing variants in the BBS9 gene are inherited in an autosomal recessive way. This means a person usually needs to inherit 2 disease-causing variants, 1 from each parent, to have a BBS9-related condition. Parents who each carry 1 variant are typically unaffected carriers. With each pregnancy, 2 carrier parents have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no familial BBS9 variant.
What does my BBS9 result mean for my family?
For families with a disease-causing change in the BBS9 gene, close relatives may also carry the same change, even if they do not have symptoms. Brothers and sisters may be affected or may be carriers, and parents are often carriers as well. Other relatives may wish to learn whether this gene change is present in the family, especially when planning children.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the BBS9 gene, doctors use genetic testing on a blood or saliva sample. Genetic testing for BBS9 variants usually reads the DNA code in this gene as part of a Bardet-Biedl syndrome panel or a broader exome test, which can help confirm a diagnosis or carrier status.
When should I consider getting a genetic test?
Consider testing for changes in the BBS9 gene if you or your child has signs of Bardet-Biedl syndrome, such as early vision problems, extra fingers or toes, unusual weight gain, or kidney problems. Testing can also help when this condition runs in the family or when a doctor is trying to confirm the cause of these symptoms.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly than others, while some are more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, have little effect in another, or cause more side effects in someone else. These differences are common and are one part of why medication response varies from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies patterns between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed and individualized treatment decisions. To learn more about this topic, you can explore the LearnHub.
Drugs influenced by the BBS9 gene
When should I seek medical advice?
There is not yet a broadly confirmed link between changes in this gene and how medicines work, so questions about symptoms, side effects, or treatment choices are best discussed with your doctor.
History
BBS9 entered medical genetics through work on Bardet-Biedl syndrome, a condition first described in the 1920s by Georges Bardet and Arthur Biedl. At that stage, doctors recognized a pattern of features seen in affected families, but the underlying genes were still unknown. From these first observations, research expanded steadily. In the early 2000s, researchers identified the BBS9 gene as one of the genes linked to Bardet-Biedl syndrome, helping show that this condition can arise from changes in several different genes. That discovery marked an important step in sorting a broad clinical picture into clearer genetic subtypes. Over time, studies of BBS9 helped strengthen the view that Bardet-Biedl syndrome is genetically diverse, with different families carrying different gene variants.